Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study
Journal of Women's Health · 2024
DOI: 10.1089/jwh.2023.1138 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Women's Health, 2024. Verfasst von Andi Camden und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Society, University of Toronto Scarborough, Toronto, Canada. Hauptthemen laut MEDLINE: Prescription Drugs, Persons with Disabilities. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Background
Individuals with disabilities may require specific medications in pregnancy. The prevalence and patterns of medication use, overall and for medications with known teratogenic risks, are largely unknown.
Methods
This population-based cohort study in Ontario, Canada, 2004-2021, comprised all recognized pregnancies among individuals eligible for public drug plan coverage. Included were those with a physical (n = 44,136), sensory (n = 13,633), intellectual or developmental (n = 2,446) disability, or multiple disabilities (n = 5,064), compared with those without a disability (n = 299,944). Prescription medication use in pregnancy, overall and by type, was described. Modified Poisson regression generated relative risks (aRR) for the use of medications with known teratogenic risks and use of ≥2 and ≥5 medications concurrently in pregnancy, comparing those with versus without a disability, adjusting for sociodemographic and clinical factors.
Results
Medication use in pregnancy was more common in people with intellectual or developmental (82.1%), multiple (80.4%), physical (73.9%), and sensory (71.9%) disabilities, than in those with no known disability (67.4%). Compared with those without a disability (5.7%), teratogenic medication use in pregnancy was especially higher in people with multiple disabilities (14.2%; aRR 2.03, 95% confidence interval [CI]: 1.88-2.20). Furthermore, compared with people without a disability (3.2%), the use of ≥5 medications concurrently was more common in those with multiple disabilities (13.4%; aRR 2.21, 95% CI: 2.02-2.41) and an intellectual or developmental disability (9.3%; aRR 2.13, 95% CI: 1.86-2.45).
Interpretation
Among people with disabilities, medication use in pregnancy is prevalent, especially for potentially teratogenic medications and polypharmacy, highlighting the need for preconception counseling/monitoring to reduce medication-related harm in pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health and Society, University of Toronto Scarborough, Toronto, Canada.
- ICES, Toronto, Canada.
- The Hospital for Sick Children, Toronto, Canada.
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Centre for Addiction and Mental Health, Toronto, Canada.
- Department of Obstetrics and Gynaecology, St. Michaels Hospital, Toronto, Canada.
Zitieren
APA
Camden, A., Grandi, S. M., Lunsky, Y., Ray, J. G., Sharpe, I., Lu, H., Guttmann, A., Tailor, L., Vigod, S., De Vera, M. A., & Brown, H. K. (2024). Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.1138
Vancouver
Camden A, Grandi SM, Lunsky Y, Ray JG, Sharpe I, Lu H, et al. Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study. Journal of Women's Health. 2024. doi:10.1089/jwh.2023.1138
BibTeX
@article{Camden2024,
author = {Camden, Andi and Grandi, Sonia M and Lunsky, Yona and Ray, Joel G and Sharpe, Isobel and Lu, Hong and Guttmann, Astrid and Tailor, Lauren and Vigod, Simone and De Vera, Mary A and Brown, Hilary K},
title = {Prescription Medication Use in Pregnancy in People with Disabilities: A Population-Based Cohort Study},
journal = {Journal of Women's Health},
year = {2024},
doi = {10.1089/jwh.2023.1138}
}
EUVIMED